KADCYLA
KADCYLA
Approved
DIN Number
02412365
Drug Class
Human
Market Date
Oct 9, 2013
Company
HC
Hoffmann-La Roche Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02412365
AIG Number0154730002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L01FD03 TRASTUZUMAB EMTANSINE
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
TRASTUZUMAB EMTANSINEActive
Strength: 100 MG / VIAL
Monograph: TRASTUZUMAB EMTANSINE